| USB |
Report |
EPS |
BEAT |
pred ~$1.31 vs. cons $1.27-1.28 |
MEDIUM |
| USB |
Report |
Net Interest Income (FTE) |
IN-LINE |
pred ~$4.35B vs. cons $4.34B |
MEDIUM |
| USB |
Report |
Total Fee/Noninterest Revenue (incl. BTIG) |
BEAT |
pred ~$3.30B vs. cons $3.20B |
MEDIUM |
| USB |
Guide |
FY2026 Total Net Revenue Growth (now incl. BTIG) |
BETTER |
guide ~7% vs. cons 5% (FY2026) |
MEDIUM |
| USB |
Guide |
FY2026 Operating Leverage Target |
BETTER |
guide ~250bps vs. cons 200bps (FY2026) |
MEDIUM |
| USB |
Guide |
NIM Trajectory (path to 3% by 2027) |
UNCHANGED |
guide ~2.80-2.85% exit vs. cons 2.80% (Q4 2026 exit rate) |
LOW |
| USB |
Return |
Day-1 residual (stock − beta × S&P 500) |
+0.8% |
— |
MEDIUM |
| USB |
Return |
5-day cumulative residual |
-1.1% (FADE) |
Most of the beat-and-raise narrative (NII toward the upper end of 6-7%, fees above range, BTIG accretion, dividend hike/SCB confirmation) was pre-announced at the June 10 Morgan Stanley conference and the stock already rallied from the low-$50s to ~$63 pricing much of it in. Because reported NII lands near the top of the already-guided range rather than blowing through it, and expense growth is intentionally stepping up (3-4%) to fund investment, out-year 2027 EPS/NIM estimates are unlikely to move up materially even after a clean Q2 beat. With valuation extended after peer bank beats (JPM, WFC) already digested, this sets up a classic sell-the-news dynamic where an initial pop fades over the following days as analysts true-up estimates only modestly versus the size of the run-up. |
LOW |